April 23, 2024

CDMO Live Europe 2026

CDMO Live Europe 2026

CDMO Live Europe 2026 

19-21 May 2026, Rotterdam

Join Europe’s Premier External Manufacturing Community at CDMO Live 2026

We are pleased to offer BioRN members 20% discount for CDMO Live Europe

CDMO Live Europe 2026 is the global meeting place for leaders in outsourced biopharma development and manufacturing.

Across three days in Rotterdam, you’ll gain actionable insights, connect with partners through curated one-to-one meetings, and experience networking like no other.

550+ external manufacturing leaders and 90+ CDMOs are gathering at CDMO Live Europe (19-21 May, Rotterdam) – the most valuable and efficient event for external manufacturing in 2026.

Our commitment is that no other external manufacturing event will give you more strategic value in 2026.

Tickets include:

  • Training Sessions – Biotech CMC Bootcamp and Strategic Partnership training sessions designed for practical application, not theory
  • PartnerMatch meetings – Pre-scheduled 1-2-1s with 90+ CDMOs matching your specific requirements. No wasted conversations.
  • 20 Outsourcing Excellence Roundtables – Peer-led discussions on supplier management, capacity planning, AI in manufacturing and Decarbonization with the PSCI
  • 40+ Manufacturing Experts Across 3 Tracks featuring analysts and executives from MSD, Roche, AstraZeneca, Daiichi Sankyo, Sandoz, J&J, Bayer and leading biotech companies
  • Unique Networking Experiences – including Cycle Tour, Rotterdam Run, and the exclusive Boat Party to create connections

Find out more: https://pharmasource.global/events/cdmolive/

 


BioRN members receive a 20 % discount.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
Member2Member: Where expertise meets the community

Member2Member: Where expertise meets the community

Every company in the bioRN network has a story to tell. More importantly, every company has knowledge that can help others move faster, avoid mistakes and spark new collaborations. That is the idea behind bioRN’s Member2Member series. Instead of traditional company presentations, Member2Member opens the doors to our member organisations and puts their expertise centre […]

BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies

BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies

Ridgefield, CT, USA, July 9, 2026 – BioMed X, a leading innovation engine for pharma, and Boehringer Ingelheim today announced the launch of a new research team at XSeed Labs, the established innovation incubator embedded within Boehringer’s U.S. R&D headquarters in Ridgefield, Connecticut. The newly established research team, Team NIB (New Platform for Next-Generation Intraocular […]

Clinical Trial on Mild Stroke: Inpatient or Outpatient Treatment?

Clinical Trial on Mild Stroke: Inpatient or Outpatient Treatment?

Researchers at Heidelberg University’s Faculty of Medicine are investigating a new care model for older adults with mild strokes at the Heidelberg University Hospital’s Department of Neurology. The Joint Federal Committee (G-BA) is funding the ARTIFICE study with approximately 2.4 million euros. Full Text in German below. Klinische Studie zu leichtem Schlaganfall: stationär oder ambulant […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp